Per Flodgren
Impact in
-
- Renal cell carcinoma treatment
- Reproductive Medicine top 10%
Papers in
-
- Prostate Cancer Diagnosis and Treatment 3
- Renal cell carcinoma treatment 3
-
- Mast cells and histamine 4
- Immune Cell Function and Interaction 2
- Co-authors
- Hans Olov Sjögren (4 shared papers)Stig G. Borgström (3 shared papers)Hakan Lars Olsson (2 shared papers)A-L Børresen (2 shared papers)Steinar Tretli (2 shared papers)S.D. Fosså (2 shared papers)Ketil Heimdal (2 shared papers)Jan Roigas (3 shared papers)
In The Last Decade
Per Flodgren
23 papers receiving 720 citations
Peers
Comparison fields: 5 of 73
- Pulmonary and Respiratory Medicine 246
- Reproductive Medicine 59
- Surgery 270
- Immunology 111
- Oncology 124
Countries citing papers authored by Per Flodgren
This map shows the geographic impact of Per Flodgren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Per Flodgren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Per Flodgren more than expected).
Fields of papers citing papers by Per Flodgren
This network shows the impact of papers produced by Per Flodgren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Per Flodgren. The network helps show where Per Flodgren may publish in the future.
Co-authors
The 25 scholars most cited alongside Per Flodgren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 171 | |
| 2 | 1996 | 102 | |
| 3 | 1983 | 72 | |
| 4 | 1982 | 67 | |
| 5 | 1997 | 65 | |
| 6 | 1996 | 43 | |
| 7 | 1990 | 42 | |
| 8 | 2003 | 37 | |
| 9 | 2018 | 35 | |
| 10 | 1985 | 28 | |
| 11 | 2009 | 18 | |
| 12 | 1984 | 15 | |
| 13 | 1994 | 14 | |
| 14 | 1984 | 11 | |
| 15 | 2000 | 10 | |
| 16 | Immune functions in melanoma patients during treatment with interferon [HuIFN-alpha (Le)] alone or in combination with cimetidine. | 1985 | 9 |
| 17 | 1993 | 9 | |
| 18 | 2009 | 8 | |
| 19 | Influence of human leukocyte interferon (HuIFN-alpha/Le/) and cimetidine on the proliferation of cultured melanoma cells in vitro. | 1985 | 4 |
| 20 | 2007 | 4 |
About Per Flodgren
Per Flodgren is a scholar working on Pulmonary and Respiratory Medicine, Immunology, Radiology, Nuclear Medicine and Imaging, Hematology and Surgery, having authored 23 papers that have together received 772 indexed citations. Recurring topics across this work include Mast cells and histamine (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Testicular diseases and treatments (4 papers), Prostate Cancer Diagnosis and Treatment (3 papers), Renal cell carcinoma treatment (3 papers), Immune Cell Function and Interaction (2 papers), Drug-Induced Adverse Reactions (2 papers) and Bladder and Urothelial Cancer Treatments (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (246 citations), Reproductive Medicine (59 citations), Surgery (270 citations), Immunology (111 citations) and Oncology (124 citations). Per Flodgren has collaborated with scholars based in Sweden, Norway and France. Frequent co-authors include Hans Olov Sjögren, Stig G. Borgström, Hakan Lars Olsson, A-L Børresen, Steinar Tretli, S.D. Fosså, Ketil Heimdal, Jan Roigas, C. Lindström and Silke Gillessen. Their work appears in journals such as Annals of Oncology, Cancer Immunology Immunotherapy, British Journal of Cancer, New England Journal of Medicine and Acta Oncologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.